Eribulin N/A All University of Washington Eribulin N/A Hormone+_HER2- Dana-Farber/Harvard Cancer Center Eribulin N/A HER2- Eisai Eribulin/cyclophospha- mide N/A All University of California, San Francisco Eribulin/carboplatin N/A All Eisai Capecitabine/digoxin N/A All Western Regional Medical Center FdCyd (5-fluoro-2'- deoxcytidine) and THU (tetrahydrouridine) N/A All National Cancer Institute Protein-bound paclitaxel N/A All City of Hope Protein-bound pacli- taxel/Anakinra (anti- inflammatory) N/A HER2- Baylor Research Institute Completed as of 8/1 Protein-bound pacli- taxel/Lapatinib N/A All University of California, San Francisco Protein-bound paclitaxel vs. IG-001 N/A All IGDRASOL Unknown as of 8/1 Tesetaxel N/A HER2- Genta Unknown as of 8/1 Tesetaxel/capecitabine  N/A HER2- Genta ThermoDox (doxoru- bicin enhanced with lysolipid thermally sensi- tive liposomes) Chemotherapy All Hyperthermia therapy Celsion  Completed as of 8/1 Heated cisplatin Chemotherapy All Surgery St. Luke's-Roosevelt Hospital Center  FOLFOX (folinic acid, fluorouracil, oxaliplatin)/ hepatic infusion Liver metas- tases All Western Regional Medical Center Unknown as of 8/1 Oral eniluracil + 5-fluoro- uracil + leucovorin N/A All MM-398/irinotecan N/A Solid Tumor Tracer for MRI imaging MerrimackPharmaceuticals IMMU-132/irinotecan N/A All Immunomedics Azacitidine N/A HER2- Protein-bound pacli- taxel University of Utah Nab-paclitaxel N/A TripleNegative With gemcitabine/ carboplatin vs. gemi- ctabine/ carboplatin alone Celgene Unknown as of 8/1 Doxorubicin/heat treat- ment N/A All National Center for Research Resources (NCRR) Ixabepilone and stereo- tactic radiation N/A TripleNegative University of Texas Southwest- ern EC1456 Folate recep- tors TripleNegative Endocyte TAS-114 Pyramidine metabolism All Capecitabine Taiho Oncology Lurbinectedin (PM01183) DNA binding All Paclitaxel with or with- out bevacizumab PharmaMar MM-302 ERB2 HER2+ With/without traztu- zumab or cyclophos- phamide Merrimack Pharmaceuticals Other Unknown as of 8/1 Whole body hyperther- mia Heat All Fluorouracil, doxoru- bicin University of Texas Surgery N/A All Radiation National Cancer Institute Study Drug(s) Target Biomarkers/ Subtype Combination Sponsor